Named on one round in the feed.
Since 2026-02-18
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$150M
across 1 round
CO-INVESTORS
5
named beside it
Named on one round in the feed.
Since 2026-02-18
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Korsana Korsana develops advanced therapeutics aimed at treating neurodegenerative diseases, particularly focusing on Alzheimer's disease. | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2026-02-18 | [ PART ] |
No sector on record.